At Creative Biolabs, we offer robust SIRT Assay Services to support the characterization of sirtuin enzymatic activity, inhibitor screening, and immune-functional pathway analysis—empowering immune-oncology research and therapeutic development.
Sirtuins (SIRTs) are a family of NAD⁺-dependent deacetylases and ADP-ribosyltransferases that orchestrate epigenetic regulation, DNA repair, metabolism, and immune signaling. In oncology, SIRTs (particularly SIRT1, SIRT2, and SIRT6) are increasingly recognized for their roles in immune evasion, T cell metabolism, tumor-associated macrophage (TAM) polarization, and PD-L1 regulation. Their modulation presents a strategic opportunity to reshape the tumor immune microenvironment (TIME).
Our SIRT assay services span multiple platforms, allowing precise interrogation of NAD⁺-dependent activity and immuno-functional consequences:
Uses acetylated lysine fluorogenic substrates to quantify activity of SIRT1–SIRT7 in real time
High-resolution analysis of deacetylation kinetics and substrate specificity under physiological or hypoxic conditions
Includes assessment of SIRT1/6 roles in NF-κB signaling, PD-L1 expression, or interferon pathway regulation
Correlate metabolic states with sirtuin activation to model immunosuppressive vs. immunostimulatory phenotypes
Platform for screening small molecules, peptides, or biologics targeting sirtuins, with readouts tied to immune gene expression
Tumor cells co-cultured with immune cells to explore SIRT-induced T cell exhaustion or macrophage polarization
A1: SIRT1, SIRT2, and SIRT6 are heavily implicated in immune regulation, including PD-L1 expression, cytokine signaling, and immune suppression.
A2: Yes. We can model glucose restriction, hypoxia, or NAD⁺/NADH alterations to mimic tumor microenvironmental stress.
A3: Absolutely. We offer tumor + T cell or macrophage co-cultures to observe SIRT effects on immune cell phenotype and function.
A4: We test small molecules, peptides, or natural compounds across SIRT1–SIRT7 using fluorometric or gene-expression-linked platforms.
A5: Yes. We offer optional transcriptomic profiling to correlate SIRT modulation with immune-related gene changes.
Creative Biolabs delivers expert-level SIRT assay platforms for researchers investigating immune metabolism, tumor suppression, and checkpoint regulation. Let us accelerate your discoveries in the immuno-oncology space.